ArticleAdvances in therapy2019

Safety Profile of HTX-019 Administered as an Intravenous Push in Cancer Patients: A Retrospective Review.

Gary D WaltonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.